In a surprising move, Dolphins star offensive lineman Terron Armstead announced his retirement after a remarkable 12-year career. Known for his leadership and skill, Armstead leaves a significant legacy in the NFL.
In a major shakeup, Kelly Day has been appointed to an expanded role at Prime Video, overseeing international originals after Jennifer Salke's exit. This move signals Amazon's new direction in global content strategy.
In a groundbreaking move, two moms in Congress are fighting for legislation that allows remote voting for new parents. Their actions have halted House business, forcing Republicans to rethink their strategy on this crucial issue.
In a controversial move, the Trump administration begins layoffs affecting major health agencies like the CDC and FDA, leading to concerns over public health safety and emergency responses.
As CinemaCon kicks off amidst Hollywood's leadership turmoil, executives face uncertain futures. With major presentations from Sony, Warner Bros, and Disney, this year’s event promises big announcements and potential shake-ups.
David Zaslav, CEO of Warner Bros. Discovery, is reportedly meeting with candidates to replace current film studio heads Michael De Luca and Pamela Abdy. The talks are in the early stages, with no final decisions made yet.
In a bold move, Trump threatens to impose steep tariffs on Russian oil if Moscow hinders peace efforts in Ukraine. With tensions escalating, he calls for a ceasefire, warning of significant economic repercussions.
In a stunning move, Dr. Peter Marks resigns from the FDA, criticizing health leadership for allowing misinformation to guide vaccination safety policies. His departure highlights ongoing concerns about public health integrity.
In a thrilling NCAA Tournament showdown, Walter Clayton Jr. led the Florida Gators to a stunning 84-79 victory over Texas Tech, securing their first Final Four appearance in 11 years. Clayton's clutch shooting and leadership shone bright as he scored 30 points, reminiscent of NBA star Steph Curry.
Peter Marks, the FDA's Center for Biologics Evaluation and Research head, resigns amid growing concerns over measles outbreaks and vaccine misinformation. His exit raises alarms about future public health initiatives.
